Drug Side Effects
Search
HYPERANDROGENISM
HYPERANDROGENISM
was reported 94 times
HYPERANDROGENISM is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
30
0.0012
1
Adrenal Steroid Synthesis Inhibitor [EPC]
1
0.0010
2
Androgen [EPC]
11
0.0004
3
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
32
0.0003
4
Progestin Antagonist [EPC]
1
0.0002
5
Somatostatin Analog [EPC]
1
0.0001
6
CD52-directed Cytolytic Antibody [EPC]
2
0.0001
7
Tissue-nonspecific Alkaline Phosphatase [EPC]
1
0.0001
8
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
4
0.0001
9
Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC]
1
0.0001
10
5-alpha Reductase Inhibitor [EPC]
5
0.0000
11
Anti-epileptic Agent [EPC]
6
0.0000
12
Aromatase Inhibitor [EPC]
3
0.0000
13
General Anesthetic [EPC]
1
0.0000
14
Mood Stabilizer [EPC]
4
0.0000
15
Methylxanthine [EPC]
1
0.0000
16
Topoisomerase Inhibitor [EPC]
1
0.0000
17
Aldosterone Antagonist [EPC]
2
0.0000
18
Alkylating Drug [EPC]
2
0.0000
19
Progestin [EPC]
2
0.0000
20
Microtubule Inhibitor [EPC]
1
0.0000
21
Vascular Endothelial Growth Factor Inhibitor [EPC]
1
0.0000
22
Atypical Antipsychotic [EPC]
2
0.0000
23
Corticosteroid [EPC]
5
0.0000
24
Opioid Agonist [EPC]
1
0.0000
25
Nucleoside Metabolic Inhibitor [EPC]
1
0.0000
26
HMG-CoA Reductase Inhibitor [EPC]
1
0.0000
27
Nonsteroidal Anti-inflammatory Drug [EPC]
1
0.0000